Barclays
IMNN icon

Barclays’s Imunon IMNN Stock Holding History

Barclays’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345 Buy
+194
New +$478 ﹤0.01% 5054
2021
Q4 		– Sell
-132
Closed -$24K – 4439
2021
Q3 		$24K Buy
132
+92
+230% +$19.1K ﹤0.01% 4341
2021
Q2 		$10K Sell
40
-69
-63% -$16.3K ﹤0.01% 4632
2021
Q1 		$29K Buy
+109
New +$36.6K ﹤0.01% 4304
2018
Q1 		– Sell
-80
Closed -$42K – 7178
2017
Q4 		$42K Buy
+80
New +$45.4K ﹤0.01% 5860
2017
Q1 		– Hold
0
– – – 6852
2016
Q4 		– Hold
0
– – – 6714
2016
Q3 		– Hold
0
– – – 6694
2016
Q2 		– Hold
0
– – – 6457
2016
Q1 		– Hold
0
– – – 6269
2015
Q3 		– Sell
-2
Closed -$11.9K – 6933
2015
Q2 		$9K Sell
2
-3
-60% -$21.3K ﹤0.01% 6143
2015
Q1 		$27K Sell
5
-1
-17% -$6.96K ﹤0.01% 5671
2014
Q4 		$32K Buy
6
+5
+500% +$34.7K ﹤0.01% 6024
2014
Q3 		$5K Sell
1
-6
-86% -$52.3K ﹤0.01% 7185
2014
Q2 		$59K Hold
7
– – ﹤0.01% 5820
2014
Q1 		$54K Hold
7
– – ﹤0.01% 5932
2013
Q4 		$54K Buy
7
+3
+75% +$35.9K ﹤0.01% 6125
2013
Q3 		$53K Buy
4
+2
+100% +$29.6K ﹤0.01% 6016
2013
Q2 		$29K Buy
+2
New +$27.8K ﹤0.01% 6644

Other funds holding IMNN

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Barclays's IMNN Position: Q2 2026 in Review

Barclays opened a new position in Imunon (IMNN) in Q2 2026: 194 shares worth $345. The stake represents ﹤0.01% of the portfolio and ranks #5054 among its holdings. This is a return to the name: Barclays previously reported a position in IMNN as recently as Q3 2021.

Barclays first reported a position in IMNN in Q2 2013 and has held it in 14 quarters since. The position peaked at $59K in Q2 2014. 23 funds tracked by Wall St. Rank hold IMNN as of Q2 2026.

  • Barclays held 194 shares of Imunon worth $345 as of Q2 2026.
  • Imunon was a new Barclays position in Q2 2026.
  • Imunon made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5054 holding.
  • Barclays first reported a position in Imunon in Q2 2013 and has held it in 14 quarters since.
  • Barclays's Imunon position peaked at $59K in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.